MITGEST (101072515)
https://cordis.europa.eu/project/id/101072515
Horizon Europe (2021-2027)
Quality Control of the Mitochondrial Gene Expression System in Health and Disease
MSCA Doctoral Networks 2021 (HORIZON-MSCA-2021-DN-01-01)
nucleic acids · immunology · oncology · physiology · RNA
2022-10-01 Start Date (YY-MM-DD)
2027-01-31 End Date (YY-MM-DD)
€ 0
Description
Mitochondria produce most of the energy the body acquires through food, and are thus pivotal players in cellular metabolism. Central to mitochondrial biology is the DNA in the organelle (mtDNA): its maintenance, correct RNA processing, and efficient translation are all essential and must be coordinated to ensure proper mitochondrial function and cellular physiology. Defective maintenance or expression of mtDNA alters energy and nutrient metabolism, which are increasingly recognized to impact medical disciplines, ranging from hundreds of genetic disorders to neurodegeneration, immunology, transmissible disease, cancer and ageing. A deep understanding of the mitochondrial gene expression system and new methods are urgently needed to develop treatments for the full panoply of mitochondrial disorders that feature mtDNA perturbation. MITGEST will unite world-class academic excellence in mtDNA maintenance and expression with private sector expertise in nucleic acid chemistry and the development of mitochondrial therapeutics to address this urgent need. As the first research training programme in this field to take a fully integrated approach, our 10 doctoral candidates (DC) will elucidate how mtDNA is maintained and expressed and support the development of new methods to analyse RNA and DNA metabolism in mitochondria. These advances will complement and facilitate/enhance innovative treatment strategies and experimental medicine studies designed to mitigate mitochondrial dysfunction in a range of human diseases. Our network of 7 beneficiaries and 12 associated partners from 8 European countries and Israel builds on proven collaborations and establishes new partnerships to deliver intersectoral and multidisciplinary scientific and transferable skills training to our 11 PhD students to generate the next generation of highly-skilled scientists able to exploit the latest advances in mitochondrial biology and medicine.
Complicit Organisations
4 Israeli organisations participate in MITGEST.Country | Organisation (ID) | VAT Number | Role | Activity Type | Total Cost | EC Contribution | Net EC Contribution |
---|---|---|---|---|---|---|---|
Poland | MIEDZYNARODOWY INSTYTUT MECHANIZMOW I MASZYN MOLEKULARNYCH POLSKIEJ AKADEMII NAUK (889429958) | PL7011013688 | coordinator | REC | € 0 | € 453,024 | € 453,024 |
Poland | INSTYTUT BIOCHEMII I BIOFIZYKI POLSKIEJ AKADEMII NAUK (998586871) | PL5261039742 | participant | REC | € 0 | € 226,512 | € 226,512 |
Netherlands | STICHTING RADBOUD UNIVERSITEIT (999992110) | NL002968721B01 | associatedPartner | HES | € 0 | € 0 | € 0 |
Netherlands | LUMICKS BV (941077220) | NL853800455B01 | associatedPartner | PRC | € 0 | € 0 | € 0 |
Italy | UNIVERSITA DEGLI STUDI DI UDINE (999899281) | IT01071600306 | associatedPartner | HES | € 0 | € 0 | € 0 |
Italy | UNIVERSITA DEGLI STUDI DI UDINE (999899281) | IT01071600306 | participant | HES | € 0 | € 0 | € 0 |
Germany | BASECLICK GMBH (953302033) | DE253905957 | participant | PRC | € 0 | € 260,539 | € 260,539 |
Spain | ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOGIPUZKOA (972652078) | ESG75020313 | participant | REC | € 0 | € 503,942 | € 503,942 |
Italy | MITOCON - INSIEME PER LO STUDIO E LA CURA DELLE MALATTIE MITOCONDRIALI - ODV (888149558) | nan | associatedPartner | OTH | € 0 | € 0 | € 0 |
Netherlands | STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM (892057785) | NL861608884B01 | participant | HES | € 0 | € 548,740 | € 548,740 |
United Kingdom | CAREERS RESEARCH AND ADVISORY CENTRE (CRAC) LIMITED (THE) (943516091) | GB100205694 | associatedPartner | OTH | € 0 | € 0 | € 0 |
Poland | INSTYTUT CHEMII BIOORGANICZNEJ POLSKIEJ AKADEMII NAUK (999586359) | PL7770002062 | associatedPartner | REC | € 0 | € 0 | € 0 |
Spain | 4BASEBIO SL (888768806) | nan | associatedPartner | REC | € 0 | € 0 | € 0 |
Israel | MINOVIA THERAPEUTICS (929687577) | IL514704485 | associatedPartner | PRC | € 0 | € 0 | € 0 |
Israel | MINOVIA THERAPEUTICS (929687577) | IL514704485 | participant | PRC | € 0 | € 0 | € 0 |
Israel | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD (952933918) | IL510097918 | participant | PRC | € 0 | € 271,432 | € 271,432 |
Italy | AGILENT TECHNOLOGIES ITALIA SPA (941201865) | IT12785290151 | associatedPartner | PRC | € 0 | € 0 | € 0 |
Italy | UNIVERSITA DEGLI STUDI DI PAVIA (999893752) | nan | associatedPartner | HES | € 0 | € 0 | € 0 |
Germany | JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN (999978724) | DE114110511 | associatedPartner | HES | € 0 | € 0 | € 0 |
Sweden | KAROLINSKA INSTITUTET (999978530) | SE202100297301 | participant | HES | € 0 | € 293,709 | € 293,709 |
United Kingdom | The Lily Foundation (888095432) | nan | associatedPartner | OTH | € 0 | € 0 | € 0 |
Israel | TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY (999907720) | IL557585585 | associatedPartner | HES | € 0 | € 0 | € 0 |
United Kingdom | UNIVERSITY COLLEGE LONDON (999975620) | GB524371168 | associatedPartner | HES | € 0 | € 0 | € 0 |
Switzerland | ACCELOPMENT SCHWEIZ AG (998454369) | CHE114132648MWST | associatedPartner | PRC | € 0 | € 0 | € 0 |
Spain | UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA (999865234) | ESQ4818001B | associatedPartner | HES | € 0 | € 0 | € 0 |
Netherlands | Predica Diagnostics BV (894576584) | nan | associatedPartner | PRC | € 0 | € 0 | € 0 |